Novartis loses initial bid to block generic of best-selling heart drug

Novartis (NOVN.S) failed to convince a Delaware federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster heart-failure drug Entresto, according to a court decision issued on Monday.